Technology
Health
Pharmaceutical

MYOS RENS

$1.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (2.34%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MYOS RENS and other stocks, options, ETFs, and crypto commission-free!

About MYOS

MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies aimed at maintaining or improving the health and performance of muscle tissue. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. Read More The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.

Employees
12
Headquarters
Cedar Knolls, New Jersey
Founded
2007
Market Cap
15.68M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
17.40K
High Today
$1.74
Low Today
$1.66
Open Price
$1.73
Volume
65.06K
52 Week High
$2.02
52 Week Low
$1.04

Collections

Technology
Health
Pharmaceutical
2016 IPO
US
North America

MYOS Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.